Immunohistochemical characterisation of pulmonary hyaline membrane in various types of interstitial pneumonia

被引:12
作者
Sun, AP
Ohtsuki, Y [1 ]
Fujita, J
Ishida, T
Yoshinouchi, T
Kohno, N
机构
[1] Kochi Med Sch, Dept Pathol, Nanko Ku, Kochi 7838505, Japan
[2] Kagawa Med Univ, Dept Internal Med, Kagawa, Japan
[3] Nagoya City Univ, Sch Med, Dept Internal Med, Nagoya, Aichi 467, Japan
[4] Hiroshima Univ, Sch Med, Dept Internal Med, Hiroshima, Japan
关键词
hyaline membrane; heterogeneity; interstitial pneumonia; immunohistochemistry; diffuse alveolar damage;
D O I
10.1097/01268031-200335020-00004
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: Hyaline membrane (HM) in diffuse alveolar damage (DAD) pattern is frequently detected in the acute stage of interstitial pneumonia (IP). To determine the exact nature of HM, we investigated immunohistochemically 25 cases of HM-containing IP. Methods: The cases examined using various kinds of antibodies were four cases associated with rheumatoid arthritis, five with usual interstitial pneumonia, two with dermatomyositis, five with viral infection, one case with progressive systemic sclerosis and eight cases caused by other agents. Results: HM mostly reacted with antibodies to PE10 (SP-A), Factor VIII, KL-6 and EMA and, interestingly, stained for AE1/AE3, CK19, and Hup-1 in some cases, but was negative for PTAH staining. However, the immunoreactivities of HM varied even within the same disease or section. Conclusions: The immunohistochemical heterogeneity of HM suggests that HM may be formed by different mechanisms in various types of IP. Our findings also suggest that the main components of HM are derived from alveolar epithelial cells and their proteins, some including cytoplasmic element of CK19, and also from serum factors, but not fibrin. The immunohistochemical characteristics of HM in DAD pattern will aid understanding of the significance of HM formation in IP.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 22 条
  • [1] The cellular and molecular biology of keratins: beginning a new era
    Coulombe, Pierre A.
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1993, 5 (01) : 17 - 29
  • [2] INTERSTITIAL LUNG-DISEASE - CURRENT CONCEPTS OF PATHOGENESIS, STAGING AND THERAPY
    CRYSTAL, RG
    GADEK, JE
    FERRANS, VJ
    FULMER, JD
    LINE, BR
    HUNNINGHAKE, GW
    [J]. AMERICAN JOURNAL OF MEDICINE, 1981, 70 (03) : 542 - 568
  • [3] IDIOPATHIC PULMONARY FIBROSIS - CLINICAL, HISTOLOGIC, RADIOGRAPHIC, PHYSIOLOGIC, SCINTIGRAPHIC, CYTOLOGIC, AND BIOCHEMICAL ASPECTS
    CRYSTAL, RG
    FULMER, JD
    ROBERTS, WC
    MOSS, ML
    LINE, BR
    REYNOLDS, HY
    [J]. ANNALS OF INTERNAL MEDICINE, 1976, 85 (06) : 769 - 788
  • [4] INTERSTITIAL LUNG-DISEASES OF UNKNOWN CAUSE .1. DISORDERS CHARACTERIZED BY CHRONIC INFLAMMATION OF THE LOWER RESPIRATORY-TRACT
    CRYSTAL, RG
    BITTERMAN, PB
    RENNARD, SI
    HANCE, AJ
    KEOGH, BA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (03) : 154 - 166
  • [5] Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders
    Dobashi, N
    Fujita, J
    Ohtsuki, Y
    Yamadori, I
    Yoshinouchi, T
    Kamei, T
    Tokuda, M
    Hojo, S
    Okada, H
    Takahara, J
    [J]. THORAX, 1998, 53 (11) : 969 - 974
  • [6] Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: Anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis
    Dobashi, N
    Fujita, J
    Murota, M
    Ohtsuki, Y
    Yamadori, I
    Yoshinouchi, T
    Ueda, R
    Bandoh, S
    Kamei, T
    Nishioka, M
    Ishida, T
    Takahara, J
    [J]. LUNG, 2000, 178 (03) : 171 - 179
  • [7] KERATINS AS BIOCHEMICAL MARKERS OF EPITHELIAL DIFFERENTIATION
    FUCHS, E
    [J]. TRENDS IN GENETICS, 1988, 4 (10) : 277 - 281
  • [8] Elevation of anti-cytokeratin 19 antibody in sera of the patients with idiopathic pulmonary fibrosis and pulmonary fibrosis associated with collagen vascular disorders
    Fujita, J
    Dobashi, N
    Ohtsuki, Y
    Yamadori, I
    Yoshinouchi, T
    Kamei, T
    Tokuda, M
    Hojo, S
    Okada, H
    Takahara, J
    [J]. LUNG, 1999, 177 (05) : 311 - 319
  • [9] GUM ET, 1993, CANCER RES, V539, P641
  • [10] Hamman L, 1944, B JOHNS HOPKINS HOSP, V74, P177